Contralateral hip fractures and other osteoporosis-related fractures in hip fracture patients: Incidence and risk factors. An observational cohort study of 1,229 patients

Archives of Orthopaedic and Trauma Surgery

Volumn 132, Issue 8, 2012, Pages 1191-1197

  Vochteloo, Anne J H ^a,b   Van Der Burg, Boudewijn L S Borger ^c   Röling, Maarten A ^b   Van Leeuwen, Diederik H ^a   Van Den Berg, Peter ^a   Niggebrugge, Arthur H P ^d   De Vries, Mark R ^a   Tuinebreijer, Wim E ^e   Bloem, Rolf M ^a   Nelissen, Rob G H H ^b   Pilot, Peter ^a  

^a REINIER DE GRAAF HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RIJNLAND HOSPITAL   (Netherlands)

^d MEDICAL CENTER HAAGLANDEN   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bilateral; Contralateral; Hip fracture; Osteoporosis; Risk factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTRALATERAL HIP FRACTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FRACTURE; HAZARD RATIO; HIGH RISK POPULATION; HIP FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBSERVATIONAL STUDY; OSTEOPOROSIS; OSTEOPOROSIS RELATED FRACTURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HIP FRACTURES; HUMANS; INCIDENCE; MALE; OSTEOPOROTIC FRACTURES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84864927748     PISSN: 09368051     EISSN: 14343916     Source Type: Journal    
DOI: 10.1007/s00402-012-1520-9     Document Type: Article

References (34)

1. Ahlborg HG, Rosengren BE, Järvinen TLN, Rogmark C, Nilsson J-A, Sernbo I et al (2010) Prevalence of osteoporosis and incidence of hip fracture in women-secular trends over 30 years. BMC Musculoskelet Disord 11:11-48
2. Cummings S, Melton L (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761-1767
3. Curran D, Maravic M, Kiefer P, Tochon V, Fardellone P (2010) Epidemiology of osteoporosis-related fractures in France: a literature review. Jt Bone Spine 77:546-551
4. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721-739
5. Johnell O, Kanis JA, Ode'n A, Sernbo I, Redlund-Johnell I, Petterson C et al (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175-179
6. Bass E, French DD, Bradham DD, Rubenstein LZ (2007) Riskadjusted mortality rates of elderly veterans with hip fractures. Ann Epidemiol 17:514-519
7. Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513-521
8. Compston J (2010) Osteoporosis: social and economic impact. Radiol Clin N Am 48:477-482
9. Hamdy RC (2009) Fracture risk assessment in postmenopausal women. Rev Endocr Metab Disord 11:229-236
10. Dell R, Greene D, Schelkun SR, Williams K (2008) Osteoporosis disease management: the role of the orthopaedic surgeon. J Bone Jt Surg Am 90(Suppl 4):188-194
11. Wehren LE, Magaziner J (2003) Hip fracture: risk factors and outcomes. Curr Osteopor Rep 1:78-85
12. Blonk MC, Erdtsieck RJ, Wernekinck MG, Schoon EJ (2007) The fracture and osteoporosis clinic: 1-year results and 3-month compliance. Bone 40:1643-1649
13. van Helden S, Cals J, Kessels F, Brink P, Dinant GJ, Geusens P (2006) Risk of new clinical fractures within 2 years following a fracture. Osteoporos Int 17:348-354
14. Lönnroos E, Kautiainen H, Karppi P, Hartikainen S, Kiviranta I, Sulkava R (2007) Incidence of second hip fractures. A population-based study. Osteoporos Int 18:1279-1285
15. Berry SD, Samelson EJ, Hannan MT, McLean RR, Lu M, Cupples LA et al (2007) Second hip fracture in older men and women: the Framingham Study. Arch Int Med 167:1971-1976
16. Owens WD, Felts JA, Spitznagel EL (1978) ASA physical status classifications: a study of consistency of ratings. Anesthesiology 49:239-243
17. Lawrence TM, Wenn R, Boulton CT, Moran CG (2010) Agespecific incidence of first and second fractures of the hip. J Bone Jt Surg Br 92:258-261
18. Chapurlat RD, Bauer DC, Nevitt M, Stone K, Cummings SR (2003) Incidence and risk factors for a second hip fracture in elderly women. The study of osteoporotic fractures. Osteoporos Int 14:130-136
19. Chiu KY, Pun WK, Luk KD, Chow SP (1992) Sequential fractures of both hips in elderly patients-a prospective study. J Trauma 32:584-587
20. Stolee P, Poss J, Cook RJ, Byrne K, Hirdes JP (2009) Risk factors for hip fracture in older home care clients. J Gerontol A Biol Sci Med Sci 64:403-410
21. Nymark T, Lauritsen JM, Ovesen O, Röck ND, Jeune B (2006) Short time-frame from first to second hip fracture in the Funen County hip fracture study. Osteoporos Int 17:1353-1357
22. Kok LM, van der Steenhoven TJ, Nelissen RG (2011) A retrospective analysis of bilateral fractures over sixteen years: localisation and variation in treatment of second hip fractures. Int Orthop 35:1545-1551
23. Chevalley T, Guilley E, Herrmann FR, Hoffmeyer P, Rapin C-H, Rizzoli R (2007) Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend. Bone 40:1284-1289
24. Fukushima T, Sudo A, Uchida A (2006) Bilateral hip fractures. J Orthop Sci 11:435-438
25. Schrøder HM, Petersen KK, Erlandsen M (1993) Occurrence and incidence of the second hip fracture. Clin Orthop Relat Res 289:166-169
26. Silverman SL, Watts NB, Delmas PD, Lange JL, Lindsay R (2007) Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study. Osteoporos Int 18:25-34
27. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA 282:1344-1352
28. Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11:83-91
29. Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH et al (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437-1443
30. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348: 1535-1541
31. Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA et al (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the fracture intervention trial. JAMA 280:2077-2082
32. Harrington JT, Ste-Marie L-G, Brandi ML, Civitelli R, Fardellone P, Grauer A et al (2004) Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis. Calcif Tissue Int 74(2):129-135
33. Pols HA, Felsenberg D, Hanley DA, Stepa'n J, Muñoz-Torres M, Wilkin TJ et al (1999) Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax international trial study group. Osteoporos Int 9:461-468
34. Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC et al (2000) Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial. FIT Research Group. J Clin Endocrinol Metab 85:4118-4124